Recruiting

CAR T-CellSolid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Sponsor:

A2 Biotherapeutics Inc.

Code:

NCT04981119

Conditions

Solid Tumor, Adult

Colorectal Cancer

Non Small Cell Lung Cancer

Pancreatic Cancer

CRC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Apheresis

Next Generation Sequencing (NGS)

Long Range NGS HLA typing

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-24. This information was provided to ClinicalTrials.gov by A2 Biotherapeutics Inc. on 2026-06-02.